Vanda Pharmaceuticals
VNDA
#7456
Rank
A$0.61 B
Marketcap
A$10.39
Share price
-4.87%
Change (1 day)
44.13%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$58.42 Million a decrease over its 2023 earnings that were of -A$20.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion222.02%
2024 -A$58.42 Million191.43%
2023 -A$20.05 Million-320.45%
2022 A$9.09 M-84.99%
2021 A$60.57 M54.8%
2020 A$39.13 M19.42%
2019 A$32.77 M4.93%
2018 A$31.23 M-228.6%
2017 -A$24.29 Million-8.98%
2016 -A$26.69 Million-53.79%
2015 -A$57.74 Million-30.18%
2014 -A$82.69 Million173.08%
2013 -A$30.28 Million-25.33%
2012 -A$40.56 Million163.61%
2011 -A$15.39 Million-221.15%
2010 A$12.69 M-124.53%
2009 -A$51.77 Million-29.44%
2008 -A$73.37 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$94.41 Million170.55%
2005 -A$34.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.54 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.58 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$17.02 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.33 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$33.17 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.54 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$4.03 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA